ArticleScientific reports2025
Prognostic comparison of partial and radical nephrectomy for T1b renal cell carcinoma with SEER database analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biopsy Provides Actionable Information Associated with Treatment Decisions for 2-7 cm Renal Masses.Cancers · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal cell carcinoma (RCC) is one of the most common tumors of the urinary system. Herein, we examined the epidemiology and prognostic factors of RCC and investigated the prognosis of partial nephrectomy (PN) compared to radical nephrectomy (RN) for T1b RCC over the past 20 years. We obtained data from the Surveillance, Epidemiology, and End Results (SEER)-17(2000-2021) database for epidemiological and survival analysis. The age-adjusted incidence of RCC per 100,000 persons significantly increased from 9.3 to 13.2 (annual percent change [APC]: 1.3%, 95% CI: 1.0-1.7). The mortality also increased from 0.8 to 4.3 (APC: 4.1%, 95% CI: 3.2-5.0). The incidence of RCC patients who underwent PN significantly increased from 0.9 to 4.7(APC:6.4%, 95% CI:4.9-7.9). Moreover, mortality for patients who underwent PN increased from 0 to 0.3% (APC: 13.0%, 95% CI: 11.4-14.6%), while mortality for those who underwent RN increased from 0.3 to 2.3% (APC: 3.6%, 95% CI: 2.2-5.0%). The multivariate Cox model indicated that PN was an independent predictor of good prognosis for both ACM and CSM, before and after propensity score matching. In addition, Kaplan-Meier survival curves showed that the RN group had a higher risk of both ACM and CSM. In the present study, we demonstrated that both the incidence and mortality of RCC have increased over the past 20 years. The number of RCC patients undergoing PN has also risen significantly in recent years. Our findings indicate that PN confers a survival benefit compared to RN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.